BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukemia
,
Lymphocyte
,
Early pregnancy factor
,
Rapamycin
,
rs2230926
,
ZBTB7A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
1 antigen
Summary
General Info
Curated Studies
Most Correlated Studies
Melanoma UKRV-Mel-15a cells resistant to MART-1
Macrophages of mice with conditional knockout of Selenocysteine tRNA (Trsp) gene
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
MAC-1 marks a quiescent and functionally superior HSC subset during regeneration.
hnRNP-A1 binds to the IRES of MELOE-1 antigen to promote MELOE-1 translation in stressed melanoma ce…
Differential effects of volatile anesthetics on leukocyte integrin macrophage-1 antigen.
Interdependence of sequential cytotoxic T lymphocyte and natural killer cell cytotoxicity against me…
Mechano-Redox Control of Mac-1 De-Adhesion by PDI Promotes Directional Movement Under Flow.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Leprosy Skin Test Antigens Phase 1
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ